I Pharaon

Publications (6)15.65 Total impact

• Source

  Available from: Thierry Lamireau

  Article: Efficacy and tolerability of racecadotril in acute diarrhea in children.

  J P Cézard, J F Duhamel, M Meyer, I Pharaon, M Bellaiche, C Maurage, J L Ginies, J M Vaillant, J P Girardet, T Lamireau, A Poujol, A Morali, J Sarles, J P Olives, C Whately-Smith, S Audrain, J M Lecomte
  [show abstract] [hide abstract]
  ABSTRACT: Oral rehydration therapy is the only treatment recommended by the World Health Organization in acute diarrhea in children. Antisecretory drugs available could not be used because of their side effects, except for racecadotril, which is efficient in acute diarrhea in adults. The efficacy and tolerability of racecadotril (1.5 mg/kg administered orally 3 times daily) as adjuvant therapy to oral rehydration were compared with those of placebo in 172 infants aged 3 months to 4 years (mean age, 12.8 months) who had acute diarrhea. The treatment groups were comparable in terms of age, duration of diarrhea, number of stools, and causative microorganism at inclusion. During the first 48 hours of treatment, patients receiving racecadotril had a significantly lower stool output (grams per hour) than those receiving placebo. The 95% confidence interval was 43%-88% for the full data set (n = 166; P = 0.009) and 33%-75% for the per-protocol population (n = 116; P = 0.001). There was no difference between treatments depending on rotavirus status. Significant differences between treatment groups were also found after 24 hours of treatment: full data set (n = 167; P = 0.026) and per-protocol population (n = 121; P = 0.015). Tolerability was good in both groups of patients. This study demonstrates the efficacy (up to 50% reduction in stool output) and tolerability of racecadotril as adjuvant therapy to oral rehydration solution in the treatment of severe diarrhea in infants and children.
  Gastroenterology 04/2001; 120(4):799-805. · 11.68 Impact Factor
• Article: 81 Efficacy and Tolerance of Acetorphan in Infant Acute Diarrhea. A Multicentric Double Blind Study

  J. P. Cézard, J. F. Duhamel, M. Meyer, I. Pharaon, M. Bellaiche, C. Maurage, J L. Ginies, J M. Vaillant, J. P. Girardet, P. Lamireau, A. Morali, J. Sarles, J P Olive, M. Besnard, H. Berard, J M. Lecomte
  Journal of Pediatric Gastroenterology and Nutrition 04/1996; 22(4):429. · 2.30 Impact Factor
• Article: [Nasal transepithelial difference of potential in mucoviscidosis. Clinical application of the measurement].

  A Maherzi, S Ategbo, I Pharaon, A Munck, J P Cezard, P Foucaud, J Navarro
  [show abstract] [hide abstract]
  ABSTRACT: To demonstrate the value of nasal transepithelial potential difference measurements in the diagnosis and assessment of therapeutic effect in cystic fibrosis. Nasal transepithelial potential difference was measured in 50 patients with cystic fibrosis (mean age 10 years) and 21 controls (mean age 8 years). There was a very significant increase in nasal transepithelial potential in cystic fibrosis patients (-28 +/- 8 mv) compared with controls (-8 +/- 3 mv) (p < 0.0001). The sensitivity and specificity of this test for the diagnosis of cystic fibrosis were 92% and 95% respectively. Nasal transepithelial potential difference was positively correlated with age (r = 0.43; p < 0.002) in cystic fibrosis patients but no correlation was found in controls. There was no significant difference in potential differences as a function of sex or Delta F508 genotype (homozygous vs heterozygous; Delta F508 vs non-Delta F508). These findings demonstrated the value of transepithelial potential difference in the diagnosis of cystic fibrosis and emphasized its capacity to assess the effect of new therapeutic protocols aimed at modifying C1- and Na+ ion transport. It could be particularly helpful for the interpretation of doubtful sweat tests.
  La Presse Médicale 03/1995; 24(9):437-40. · 0.67 Impact Factor
• Article: Long-term parenteral nutrition in children who are potentially candidates for small bowel transplantation.

  I Pharaon, C Despres, Y Aigrain, A Grini, C Faure, P Matarazzo, J Navarro, L Cathelineau, J P Cezard
  Transplantation Proceedings 07/1994; 26(3):1442. · 1.00 Impact Factor
• Article: [Quality of life of children with home parenteral nutrition and of their parents].

  I Loras Duclaux, S De Potter, I Pharaon, J P Olives, M Hermier
  [show abstract] [hide abstract]
  ABSTRACT: Thanks to the technical progresses during the last decade and to the active participation of parents, parenteral nutrition may be undertaken at home in patients with chronic digestive or extra-digestive diseases with serious undernutrition. This technique being highly sophisticated and demanding, we have undertaken a study of the quality of life of 44 children submitted to home parenteral nutrition and followed by the four registered French centres of pediatric nutrition. This study shows that home parenteral nutrition improves the quality of life of both children and parents as compared with the preceding period in the hospital. However, because of its constraints, it requires a careful evaluation of the parents' capacity to cope with, before to be undertaken.
  Pédiatrie 02/1993; 48(7-8):555-60.
• Article: [Digital clubbing and childhood Crohn disease].

  A Munck, P M Priez, I Pharaon, D Murciano, P Guran, J Navarro
  Archives françaises de pédiatrie 11/1991; 48(8):590.